A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Dacomitinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Dacomitinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Dacomitinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Dacomitinib Related Compounds

Stable Isotopes

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Dacomitinib D10 dihydrochloride Stable Isotopes CS-CX-00773 1110813-31-4 (Unlabeled) Enquire
Dacomitinib D3 Stable Isotopes CS-O-13266 1110813-31-4 (Unlabeled) Enquire
Dacomitinib D5 Stable Isotopes CS-O-13264 1110813-31-4 (Unlabeled) Enquire
Dacomitinib-d10 Stable Isotopes CS-EO-02775 1110813-31-4 (Unlabelled) In Stock
O- Desmethyl Dacomitinib D5 Stable Isotopes CS-O-13265 Not Available Enquire


API Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Dacomitinib API Standards CS-O-11328 1110813-31-4 Enquire
Dacomitinib Monohydrate API Standards CS-ED-41475 1042385-75-0 In Stock


Impurities

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-... Impurities CS-O-37056 2190490-31-2 Enquire
Dacomitinib N-oxide impurity Impurities CS-O-53903 Not Available Enquire